Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of engineering drug-specific hypersensitive t-cells for immunotherapy by gene inactivation

Method of engineering drug-specific hypersensitive t-cells for immunotherapy by gene inactivation

US Patent 10894093 · Granted Jan 19, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeted gene insertion for improved immune cells therapy2025
Targeted gene insertion for improved immune cells therapy2025
Targeted gene insertion for improved immune cells therapy2025
Method for improving production of car T cells2025
Method for improving production of car T cells2025
Regulation of gene expression via aptamer-mediated control of self-cleaving ribo2025
Method for generating t-cells compatible for allogenic transplantation2025
Method for generating t-cells compatible for allogenic transplantation2025
Targeted gene integration of CRS inhibitor genes for improved immune cells thera2025
Targeted gene integration of CRS inhibitor genes for improved immune cells thera2025
Targeted gene integration of CRS inhibitor genes for improved immune cells thera2025
Targeted gene integration of NK inhibitors genes for improved immune cells thera2025